Activation of transcription factor NF-κB by growth inhibitory cytokines in vulvar carcinoma cells

Immunology Letters

Volumn 74, Issue 2, 2000, Pages 103-109

  Seppänen, Marjo ^a   Vihko, Kimmo K ^a  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

AP 1; Cytokines; NF B; Transcription factors; Vulvar carcinoma

Indexed keywords

CYTOKINE; DNA BINDING PROTEIN; GAMMA INTERFERON; GROWTH INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 13; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; ELECTROPHORETIC MOBILITY; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VULVA CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYTOKINES; ELECTROPHORESIS; FEMALE; HUMAN; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; INTERLEUKIN-13; NF-KAPPA B; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR; VULVAR NEOPLASMS;

EID: 0342844343     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(00)00204-2     Document Type: Article

References (35)

1. Kaufman R.H. Intraepithelial neoplasia of the vulva. Gynecol. Oncol. 56:1995;8-21.
2. Messing W., Gallup D.G. Carcinoma of the vulva in young women. Obstet. Gynecol. 86:1995;51-54.
3. Sherman K.J., Daling J.R., Chu J., Weiss N.S., Ashley R.L., Corey L. Genital warts, other sexually transmitted diseases, and vulvar cancer. Epidemiol. 2:1991;257-262.
4. Hietanen S., Grénman S., Syijänen K., Lappalainen K., Kauppinen J., Carey T., Syrjänen S. Human papillomavirus in vulvar and vaginal carcinoma cell lines. Br. J. Cancer. 72:1995;134-139 (A).
5. Hietanen S., Kurvinen K., Syrjänen K., Grénman S., Carey T., McClatchey K., Syrjänen S. Mutations of tumor supressor gene p53 is frequently found in vulvar carcinoma cells. Am. J. Obstet. Gynecol. 173:1995;1477-1482 (B).
6. Vihko K.K., Seppänen M., Henttinen T., Punnonen J., Grénman S., Punnonen R. Regulation of UM-SCV-1A and UM-SCV-6 vulvar carcinoma cell proliferation by cytokines. Cancer Immunol. Immunother. 43:1997;368-374.
7. Baldwin, A.S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Ann Rev Immunol 14, 649-681.
8. Dejardin E., Deregowski V., Chapelier M., Jacobs N., Gielen J., Merville M-P., Bour V. Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells. Oncog. 18:1999;2567-2577.
9. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
10. Seppänen M., Henttinen T., Lin L., et al. Inhibitory effect of cytokines on ovarian and endometrial carcinoma cells in vitro with special reference to induction of specific transcriptional regulators. Oncol. Res. 10:1998;575-589.
11. Seppänen, M., Lin, L., Punnonen, J, Grénman, S., Punnonen, R., Vihko, K.K. (1999) Regulation of UT-OC-3 ovarian carcinoma cell proliferation by cytokines: Inhibitory effects on cell proliferation and activation of transcription factors AP-1 and NF-κB. Eur J Endo (in press).
12. Grénman S.E., Van Dyke D.L., Worsham M.J., et al. Phenotypic characterization, karyotype analysis in vitro tamoxifen sensivity of new er-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int. J. Cancer. 45:1990;920-927.
13. Worsham M.J., Van Dyke D.L., Grénman S.E., et al. Consistent chromosome abnormalities in squamous cell carcinoma of the vulva. Genes Chromosomes Cancer. 3:1991;420-432.
14. Andrews N., Faller D. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucl. Acids Res. 19:1991;249.
15. Itri L. The interferons. Cancer. 70:1992;940-945.
16. Bollag W., Peck R., Frey J.R. Inhibition of proliferation by retinoids, cytokines and their combination in four human transformed epithelial cell lines. Cancer Lett. 62:1992;167-172.
17. Gallois, C., Habib, A., Tao, J., Moulin, S., Maclouf J, Mallat, A., Lotersztajn, S. (1998) Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclo-oxygenase-2., J Biol Chem 273, 23183-23190.
18. Bours V., Dejardin F., Goujon-Letawe R., Merville M-P., Castronovo V. The NF-κB transcription factor and cancer: high expression of NF-κB- and IκB-related proteins in tumor cell lines. Biochem. Pharmacol. 47:1994;145-149.
19. Sovak M., Bellas R., Kim D., Zanieski G., Rogers A., Traish A.M., Sonenshein G.E. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:1997;2952-2960.
20. Wu, M., Lee, R, Bellas, R.E., Schauer, S.L., Arsura, M., Katz, FitzGerald, M.J., Rothstein, T.L, Sherr, D.H., Sonenshein, G.E. (1996) Inhibition of NF-κB/Rel. induces apoptosis of murine B cells. EMBO J 15, 4682-4690.
21. van Hogerlinden, M., Rozell B.L., Ahrlund-Richter, L., Tofgard, R. (1999) Squamous cell carcinomas and incresed apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res 59, 3299-3303.
22. Wang C.Y., Mayo M.W., Baldwin A.S. Jr. TNF-α and cancer therapyinduced apoptosis: potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
23. Beg A.A., Baltimore D. An essential role for NF-κB in preventing TNF-α induced cell death. Science. 274:1996;782-784.
24. Eliopoulos A., Kerr D., Herod J., Hodkings L., Krajewski S. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene. 11:1995;1217-1228.
25. Zhu Y-M, Bradbury D., Russell N.H. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br. J. Cancer. 69:1994;468-472.
26. Rantanen V., Grénman S., Kurvinen K., Hietanen S., Raitanen M., Syrjänen S. P53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines. Gynecol. Oncol. 71:1998;352-358.
27. Hurme M., Henttinen T., Karppelin M., Varkila K., Matikainen S. Effect of interleukin-10 on NF-κB and AP-1 activities in interleukin-2 dependent CD8 T lymphoblasts. Immunol. Lett. 42:1994;129-133.
28. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)10 inhibits nuclear factor κB (NF-κB) activation in human monocytes. J. Biol. Chem. 270:1995;9558-9563.
29. Manna S.K., Aggarwal B.B. IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis. J. Immunol. 161:1998;2863-2872.
30. Bauerle P.A., Baichwal V.R. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65:1997;111.
31. Sikora E., Grassilli E., Bellesia E., Troiano L., Franceschi C. Studies of the relationship between cell proliferation and cell death. AP-1 DNA- binding activity during concavalin A-induced proliferation or dexamethasone-induced apoptosis of rat thymocytes. Bochem. Biophys. Res. Com. 192:1993;386-388.
32. Dixit V.M., Marks R.M., Sarma V., Prochownik E.V. The antimitogenic action of tumor necrosis factor is accociated with increased AP-1/ c-jun proto-oncogene transcription. J. Biol. Chem. 264:1989;16905-16909.
33. Brach M., Gruss H., Sott C., Herrmann F. The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1. Mol. Cell. Biol. 13:1993;4284-4290.
34. Hyder S.M., Nawaz Z., Chiappetta C., Yokoyama K. The protooncogene c-jun contains estrogen-inducible enhancer within the coding sequence. J. Biol. Chem. 270:1995;8506-8513.
35. Kalkhoven E., Wissink S., van der Saag P.T., van der Burg B. Negative interaction between the RelA(p65) subunit of NF-κB and the progesterone receptor. J. Biol. Chem. 271:1996;6217-6224.